Biolidics(8YY.SI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

8YY.SI Biolidics

Trading 11-05 13:00:00 SGT Delay

0.0090

+0.0000

0.00%

High0.0090	Low0.0090	Vol0.00
Open0.0090	D1 Closing0.0090	Amplitude0.00%
Mkt Cap6.70M	Tradable Cap6.70M	Total Shares744.76M
T/O0.00	T/O Rate0.00%	Tradable Shares744.76M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"8YY.SI","market":"SI","secType":"STK","nameCN":"Biolidics","latestPrice":0.009,"timestamp":1730782800047,"preClose":0.009,"halted":0,"volume":0,"delay":15,"nameEN":"Biolidics","floatShares":744758836,"shares":744758836,"eps":-0.003739,"marketStatus":"Trading","change":0,"latestTime":"11-05 13:00:00 SGT Delay","open":0.009,"high":0.009,"low":0.009,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.003739,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1730798160000},"marketStatusCode":2,"adr":0,"exchange":"SGX","adjPreClose":0.009,"openAndCloseTimeList":[[1730766600000,1730779200000],[1730782800000,1730798160000]],"volumeRatio":0,"lotSize":100,"tradeCurrency":"SGD"},"requestUrl":"/m/hq/s/8YY.SI/tweets","defaultTab":"tweets","newsList":[{"id":"2480425383","title":"Biolidics Trims Loss in Q3 as Revenue Rises 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480425383","media":"MT Newswires","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480425383?lang=en_us&edition=fundamental","pubTime":"2024-11-04 12:02","pubTimestamp":1730692966,"startTime":"0","endTime":"0","summary":"Biolidics  loss for the third quarter of the year stood at SG$420,000, down nearly 30% year over year from SG$596,000, a filing with the Singapore Exchange said on Friday.Loss per share came in at SG$0.0006 from SG$0.0007 in the year-ago period.The diagnostic solutions provider's revenue was up 7% year over year to SG$15,000 from SG$14,000, mainly due to a slight increase in revenue from sales of CTChip FR1 biochip.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["8YY.SI"],"gpt_icon":0},{"id":"2477530500","title":"Singapore Shares Surge as Inflation Eases Up; SingPost Rises 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477530500","media":"MT Newswires","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477530500?lang=en_us&edition=fundamental","pubTime":"2024-10-23 18:03","pubTimestamp":1729677784,"startTime":"0","endTime":"0","summary":"Singapore's stock market surged on Wednesday, as US Treasury yields rose with Singapore's inflation easing up.The Straits Times Index , a key benchmark for the Singapore Exchange, ranged between 3,587.89 and 3,616.84 throughout the day. It ended the session at 3,600.78, up 13.37 points or 0.37% compared to Tuesday's close.In economic news, Singapore's headline consumer price index, or overall inflation, eased up 2.0% year on year in September from 2.2% in August, largely due to a steeper fall in private transport costs.In company news, shares of Biolidics  surged nearly 13% after the company completed the acquisition of Shenzhen Xiaozhao Network Technology through its wholly owned subsidiary, Embracing Future E-Sports.Grand Bank Yachts'  shares zoomed over 6% at the close after the luxury yacht maker's after-tax profit was up 95% year over year to SG$5.4 million for the fiscal first quarter ended Sept. 30, from SG$2.8 million a year earlier.Meanwhile, shares of Keppel Pacific Oak US RE","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["C6L.SI","CMOU.SI","BK6012","BK6511","D05.SI","8YY.SI","BK6505","BK6065","S08.SI","Z59.SI","NIO.SI","BK6099","STI.SI","5E2.SI","O39.SI","U11.SI","BK6512","S59.SI","G50.SI","BK6132"],"gpt_icon":1},{"id":"2477732802","title":"Biolidics Completes Acquisition of Shenzhen Xiaozhao Network Technology; Shares Surge 13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477732802","media":"MT Newswires","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477732802?lang=en_us&edition=fundamental","pubTime":"2024-10-23 12:22","pubTimestamp":1729657378,"startTime":"0","endTime":"0","summary":"Biolidics  completed the acquisition of Shenzhen Xiaozhao Network Technology through its wholly owned subsidiary, Embracing Future E-Sports, a filing with the Singapore Exchange said on Tuesday.The move is part of the company's aim to enhance its penetration in the e-sports industry.Shares of the medical services company surged nearly 13% in recent trading.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["8YY.SI","BK6511","BK6012"],"gpt_icon":0},{"id":"2477469381","title":"Biolidics Limited Completion of the Proposed Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2477469381","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477469381?lang=en_us&edition=fundamental","pubTime":"2024-10-22 18:47","pubTimestamp":1729594026,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241022:nTUEBTFLGM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["8YY.SI","BK6511","BK6012"],"gpt_icon":0},{"id":"2473126371","title":"Biolidics Responds to SGX Queries on Share Issuance to Vendors Under Acquisition Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2473126371","media":"MT Newswires","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473126371?lang=en_us&edition=fundamental","pubTime":"2024-10-07 10:08","pubTimestamp":1728266928,"startTime":"0","endTime":"0","summary":"Biolidics  has addressed queries from the Singapore Exchange regarding its recent issuance of 946 million new ordinary shares, according to a Monday filing on the Singapore Exchange.Shares of the medical technology company were allocated to vendors Yuan Zhijun and Wu Kunwei before the completion of a proposed acquisition.The company explained that the early issuance was necessitated by the listing and quotation notice's requirement to issue shares within seven market days.Additionally, the timing was influenced by anticipated delays in securing approvals from Chinese regulatory authorities due to the Golden Week holiday.The issuance aims to prevent potential mandatory takeover obligations under Singapore's Takeovers Code, ensuring that the subscription does not trigger such a requirement.All acquisition conditions have been fulfilled, with the completion expected around Oct. 25, pending further approvals from PRC governmental agencies.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK6012","8YY.SI","BK6511"],"gpt_icon":0},{"id":"2472605253","title":"Biolidics Issues 946 Million New Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2472605253","media":"MT Newswires","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472605253?lang=en_us&edition=fundamental","pubTime":"2024-10-04 10:49","pubTimestamp":1728010143,"startTime":"0","endTime":"0","summary":"Diagnostics firm Biolidics  has completed the issuance of 946 million new ordinary shares, according to a Thursday filing on the Singapore Exchange.The issue includes 452 million shares to shareholders Yuan Zhijun and Wu Kunwei, 407 million to Zhu Hua, 76 million to Chen Lu, and 11 million to Icon Law, the filing said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK6012","BK6511","8YY.SI"],"gpt_icon":0},{"id":"2471281454","title":"Biolidics Receives SGX Approval to List 946 Million Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2471281454","media":"MT Newswires","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2471281454?lang=en_us&edition=fundamental","pubTime":"2024-09-30 10:42","pubTimestamp":1727664139,"startTime":"0","endTime":"0","summary":"Biolidics  has received the listing and quotation notice from the Singapore Exchange to list and quote 946 million new shares, according to a Monday filing on the Singapore Exchange.This includes 452 million shares to shareholders Yuan Zhijun and Wu Kunwei, 407 million subscription shares to Zhu Hua, 76 million sign on shares to Chen Lu, and 11 million to Icon Law LLC.The company must place out these shares within seven market days.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK6012","BK6511","8YY.SI"],"gpt_icon":0},{"id":"2462898268","title":"Biolidics Amends Share Subscription Agreement with Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2462898268","media":"MT Newswires","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2462898268?lang=en_us&edition=fundamental","pubTime":"2024-08-26 10:00","pubTimestamp":1724637651,"startTime":"0","endTime":"0","summary":"Biolidics  entered into a supplemental agreement to amend the recently disclosed share subscription deal with Chairman Zhu Hua, according to a Friday filing on the Singapore Exchange.Under the revised terms, the subscription amount of SG$1.6 million will be partially set off against the outstanding debt owed to Zhu.The remaining subscription amount will be paid in cash.As disclosed last month, the medical device maker agreed to issue up to 407,000,000 new ordinary shares to Zhu at S$0.0040 apiece.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK6012","8YY.SI","BK6511"],"gpt_icon":1},{"id":"2457474117","title":"Singapore Shares Tumble as Retail Sales Drop; DBS Plunges 5.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457474117","media":"MT Newswires","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2457474117?lang=en_us&edition=fundamental","pubTime":"2024-08-05 18:00","pubTimestamp":1722852000,"startTime":"0","endTime":"0","summary":"Singapore's stock market tumbled on Monday, mirroring overnight losses in the US market after the release of the country's poor job data and Singapore's retail sales drop.The Straits Times Index , a key benchmark for the Singapore Exchange, ranged between 3,211.78 and 3,315.95 throughout the day. It ended the session at 3,243.67, down 137.78 points or 4.07% compared to Friday's close.In economic news, Singapore's private sector expanded robustly in July, with the S&P Global Singapore Purchasing ","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["C6L.SI","8YY.SI","5DP.SI"],"gpt_icon":1},{"id":"2457198487","title":"Biolidics Enters Supplemental Agreement Tied to Shenzhen Network Technology Acquisition; Biolidics Shares Plummet 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457198487","media":"MT Newswires","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2457198487?lang=en_us&edition=fundamental","pubTime":"2024-08-05 14:52","pubTimestamp":1722840769,"startTime":"0","endTime":"0","summary":"Biolidics  entered into a supplemental agreement with Yuan Zhi Jun and Wu Kun Wei in relation the 100% acquisition of Shenzhen Network Technology, a filing with the Singapore Exchange said on Friday.Under the supplemental agreement, the definition of the earn-out period under the sale and purchase agreement will be amended to mean the 12-month period commencing from the day of acquisition completion.Earlier, the company had entered into a conditional sale and purchase agreement with the individuals for the acquisition of Shenzhen Network Technology for a purchase consideration of SG$2.8 million by way of allotment and issuance of 316,400,000 shares equivalent to 70% of the total shares and SG$1.2 million of purchase consideration by way of allotment and issuance of up to 135,600,000 shares equivalent to 30% of the total aggregate earn-out consideration shares.Shares of the medical research company plunged 10% in recent trading.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["8YY.SI","BK6012","BK6511"],"gpt_icon":1},{"id":"2456277474","title":"Biolidics Limited Entry Into Supplemental Letter Agreement in Relation to the Proposed Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2456277474","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2456277474?lang=en_us&edition=fundamental","pubTime":"2024-08-02 17:32","pubTimestamp":1722591128,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240802:nTUE9QLFWC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK6511","8YY.SI","BK6012"],"gpt_icon":0},{"id":"2456297141","title":"Biolidics Incorporates Two Subsidiaries","url":"https://stock-news.laohu8.com/highlight/detail?id=2456297141","media":"MT Newswires","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2456297141?lang=en_us&edition=fundamental","pubTime":"2024-08-01 13:44","pubTimestamp":1722491047,"startTime":"0","endTime":"0","summary":"Biolidics  incorporated two subsidiaries, Embracing Future E-Sports and Embracing Future MCN Technology, according to a filing with the Singapore Exchange on Wednesday.The incorporation of both subsidiaries was funded through internal resources and will not impact the company's earnings per share for the year ending Dec. 31.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["8YY.SI"],"gpt_icon":0},{"id":"2454306895","title":"Biolidics to Buy Shenzhen Xiaozhao Network; Secures SG$1.5 Million Loan","url":"https://stock-news.laohu8.com/highlight/detail?id=2454306895","media":"MT Newswires","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2454306895?lang=en_us&edition=fundamental","pubTime":"2024-07-25 10:48","pubTimestamp":1721875682,"startTime":"0","endTime":"0","summary":"Biolidics (SGX:8YY) has signed an agreement to acquire Shenzhen Xiaozhao Network Technology from Dreamsgame, which would make the target a wholly-owned subsidiary upon completion, according to a Wedne","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK6511","BK6012","8YY.SI"],"gpt_icon":0},{"id":"2453932883","title":"Biolidics Ltd - Entered Into a Conditional Sale and Purchase Agreement With Dreamsgame","url":"https://stock-news.laohu8.com/highlight/detail?id=2453932883","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2453932883?lang=en_us&edition=fundamental","pubTime":"2024-07-24 21:49","pubTimestamp":1721828949,"startTime":"0","endTime":"0","summary":"Biolidics Ltd - Entered Into a Conditional Sale and Purchase Agreement With Dreamsgame","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240724:nFWN3JG1TJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK6012","BK6511","8YY.SI"],"gpt_icon":0},{"id":"2453883967","title":"Biolidics Ltd -  Entered Into Loan Agreement With Chairman for S$1.5 Mln Loan","url":"https://stock-news.laohu8.com/highlight/detail?id=2453883967","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2453883967?lang=en_us&edition=fundamental","pubTime":"2024-07-24 21:49","pubTimestamp":1721828949,"startTime":"0","endTime":"0","summary":"Biolidics Ltd -  Entered Into Loan Agreement With Chairman for S$1.5 Mln Loan","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240724:nFWN3JG1TJ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK6012","BK6511","8YY.SI"],"gpt_icon":0},{"id":"2453883697","title":"Biolidics Ltd -  Total Consideration for Purchase of Stake in Shenzhen Xiaozhao Network Technology S$4.1 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2453883697","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2453883697?lang=en_us&edition=fundamental","pubTime":"2024-07-24 21:49","pubTimestamp":1721828949,"startTime":"0","endTime":"0","summary":"Biolidics Ltd -  Total Consideration for Purchase of Stake in Shenzhen Xiaozhao Network Technology S$4.1 Mln","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240724:nFWN3JG1TJ:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK6511","TSS","BK6012","8YY.SI"],"gpt_icon":0},{"id":"2446254580","title":"Biolidics Names Ex-Weiye Executive as Financial Controller","url":"https://stock-news.laohu8.com/highlight/detail?id=2446254580","media":"MT Newswires","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446254580?lang=en_us&edition=fundamental","pubTime":"2024-06-28 11:30","pubTimestamp":1719545407,"startTime":"0","endTime":"0","summary":"Biolidics  appointed Lau Wei Kian as the company's financial controller, effective July 1, according to a Thursday filing on the Singapore Exchange.Kian, a resident of Singapore, brings experience in financial management, having served as financial controller at Pollux Properties from 2019 and Weiye Holdings since 2013.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK6511","BK6012","8YY.SI"],"gpt_icon":0},{"id":"2444846041","title":"Biolidicsâ CEO Steps Down; Shares Surge 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444846041","media":"MT Newswires","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2444846041?lang=en_us&edition=fundamental","pubTime":"2024-06-17 11:24","pubTimestamp":1718594662,"startTime":"0","endTime":"0","summary":"Biolidics (SGX:8YY) chief executive officer and director, Song Tang Yih will step down from his position, effective, June 30, to pursue other career opportunities, according to a filing with the Singapore Exchange on Friday. Shares of the company were up 10% in recent trading.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["8YY.SI"],"gpt_icon":0},{"id":"2443167979","title":"Biolidics Announces Resignation Of Song Tang Yih As Executive Director And CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2443167979","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2443167979?lang=en_us&edition=fundamental","pubTime":"2024-06-14 22:47","pubTimestamp":1718376463,"startTime":"0","endTime":"0","summary":"Biolidics Ltd :Resignation Of Song Tang Yih As Executive Director And Ceo.Further Company Coverage: Biol.Si. ((Reuters.Briefs@Thomsonreuters.Com;)).","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.trkd.thomsonreuters.com","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK6511","8YY.SI","BK6012"],"gpt_icon":0},{"id":"2443675606","title":"Biolidics - Resignation of Song Tang Yih as Executive Director and CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2443675606","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2443675606?lang=en_us&edition=fundamental","pubTime":"2024-06-14 22:11","pubTimestamp":1718374262,"startTime":"0","endTime":"0","summary":"Biolidics - Resignation of Song Tang Yih as Executive Director and CEO","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240614:nFWN3IC0IA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK6511","8YY.SI","BK6012"],"gpt_icon":0}],"profile":{"websiteUrl":"https://www.biolidics.com/","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":-0.1818},{"period":"1year","weight":-0.25},{"period":"ytd","weight":-0.3571}],"compareEarnings":[{"period":"1week","weight":-0.0058},{"period":"1month","weight":-0.0027},{"period":"3month","weight":0.1299},{"period":"6month","weight":0.1194},{"period":"1year","weight":0.1898},{"period":"ytd","weight":0.1517}],"compareStock":{"symbol":"ES3.SI","name":"STI ETF"},"description":"Biolidics Limited is a Singapore-based precision medicine medical technology company. The Company's principal activities are technology development, technology transfer, marketing, selling and distribution of biomedical technology, life and medicine science related products and services; provision of laboratory services; and investment holding. It has three segments: cancer diagnostics, infectious diseases and laboratory services. Cancer diagnostics segment develops and commercializes the ClearCell FX1 System, a fully automated CE-IVD medical device, which separate and enrich cancer cells from blood, allows users of the system to perform liquid biopsies. Infectious diseases segment develops, markets and/or distributes certified test kits with various diagnostic partners. Laboratory services segment offers a range of tests. The laboratory has a regulatory approval from Singapore’s Ministry of Health for molecular microbiology testing and PCR testing services for COVID-19 in Singapore.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.070428},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.030064},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.024687},{"month":4,"riseRate":0.666667,"avgChangeRate":0.149331},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.072585},{"month":6,"riseRate":0,"avgChangeRate":-0.103976},{"month":7,"riseRate":0.333333,"avgChangeRate":0.029424},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.186829},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.008846},{"month":10,"riseRate":0.166667,"avgChangeRate":0.004484},{"month":11,"riseRate":0.333333,"avgChangeRate":0.023595},{"month":12,"riseRate":0.2,"avgChangeRate":-0.068619}],"exchange":"SGX","name":"Biolidics","nameEN":"Biolidics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Biolidics(8YY.SI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Biolidics(8YY.SI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Biolidics,8YY.SI,Biolidics股票,Biolidics股票老虎,Biolidics股票老虎国际,Biolidics行情,Biolidics股票行情,Biolidics股价,Biolidics股市,Biolidics股票价格,Biolidics股票交易,Biolidics股票购买,Biolidics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Biolidics(8YY.SI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Biolidics(8YY.SI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction